SHC stock icon

Sotera Health

13.88 USD
-0.43
3.00%
At close Nov 18, 4:00 PM EST
After hours
13.88
+0.00
0.00%
1 day
-3.00%
5 days
-13.25%
1 month
-13.25%
3 months
-7.03%
6 months
25.16%
Year to date
-17.13%
1 year
-0.36%
5 years
-44.70%
10 years
-44.70%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.

Employees: 3,000

0
Funds holding %
of 6,704 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

123% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 44

41% more capital invested

Capital invested by funds: $3.13B [Q2] → $4.41B (+$1.28B) [Q3]

38% more funds holding in top 10

Funds holding in top 10: 8 [Q2] → 11 (+3) [Q3]

0.09% more ownership

Funds ownership: 93.21% [Q2] → 93.3% (+0.09%) [Q3]

9% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 34

1% less funds holding

Funds holding: 205 [Q2] → 202 (-3) [Q3]

11% less call options, than puts

Call options by funds: $1.15M | Put options by funds: $1.3M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$20
44%
upside
Avg. target
$20
44%
upside
High target
$20
44%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Citigroup
Patrick Donnelly
34% 1-year accuracy
12 / 35 met price target
44%upside
$20
Buy
Maintained
6 Nov 2024

Financial journalist opinion

Based on 6 articles about SHC published over the past 30 days

Charts implemented using Lightweight Charts™